MARÍA PILAR
GARCÍA ALFONSO

Profesora titular de universidad

Foto de MARÍA PILAR

Foto de Christie Hospital NHS Foundation Trust

Christie Hospital NHS Foundation Trust

Mánchester, Reino Unido

Publicaciones en colaboración con investigadores/as de Christie Hospital NHS Foundation Trust (5)

2022

First-line trifluridine/tipiracil + bevacizumab in patients with unresectable metastatic colorectal cancer: final survival analysis in the TASCO1 study
British Journal of Cancer, Vol. 126, Núm. 11, pp. 1548-1554

2020

Trifluridine/tipiracil plus bevacizumab in patients with untreated metastatic colorectal cancer ineligible for intensive therapy: the randomized TASCO1 study
Annals of Oncology, Vol. 31, Núm. 9, pp. 1160-1168

2019

Ramucirumab with cisplatin and fluoropyrimidine as first-line therapy in patients with metastatic gastric or junctional adenocarcinoma (RAINFALL): a double-blind, randomised, placebo-controlled, phase 3 trial
The Lancet Oncology, Vol. 20, Núm. 3, pp. 420-435

2018

Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trial
The Lancet, Vol. 392, Núm. 10142, pp. 123-133

2003

Oral capecitabine as an alternative to i.v. 5-fluorouracil-based adjuvant therapy for colon cancer: Safety results of a randomized, phase III trial
Annals of Oncology, Vol. 14, Núm. 12, pp. 1735-1743